LSL Pharma Group (TSXV:LSL) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Apr. 14, 2025)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

LSL Pharma Group (TSXV:LSL) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

LSL Pharma Group Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6

Website

https://www.laboratoirelsl.com

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines